These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 2162235)
1. Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist. Criswell HE; Mueller RA; Breese GR Brain Res; 1990 Apr; 512(2):284-90. PubMed ID: 2162235 [TBL] [Abstract][Full Text] [Related]
2. Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. Criswell H; Mueller RA; Breese GR J Neurosci; 1989 Jan; 9(1):125-33. PubMed ID: 2521511 [TBL] [Abstract][Full Text] [Related]
3. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
4. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Huang KX; Bergstrom DA; Ruskin DN; Walters JR Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257 [TBL] [Abstract][Full Text] [Related]
6. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons. Van De Witte SV; Groenewegen HJ; Voorn P Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors. Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972 [TBL] [Abstract][Full Text] [Related]
9. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. Breese GR; Napier TC; Mueller RA J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987 [TBL] [Abstract][Full Text] [Related]
10. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
11. Phencyclidine supersensitivity in rats with neonatal dopamine loss. Moy SS; Breese GR Psychopharmacology (Berl); 2002 May; 161(3):255-62. PubMed ID: 12021828 [TBL] [Abstract][Full Text] [Related]
12. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat. Campbell BM; Kreipke CW; Walker PD Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829 [TBL] [Abstract][Full Text] [Related]
14. D1 dopamine and NMDA receptors interactions in the medial prefrontal cortex: modulation of spatial working memory in rats. Rios Valentim SJ; Gontijo AV; Peres MD; Rodrigues LC; Nakamura-Palacios EM Behav Brain Res; 2009 Dec; 204(1):124-8. PubMed ID: 19482047 [TBL] [Abstract][Full Text] [Related]
15. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions. Boldry RC; Chase TN; Engber TM J Pharmacol Exp Ther; 1993 Dec; 267(3):1454-9. PubMed ID: 7903390 [TBL] [Abstract][Full Text] [Related]
16. Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson: differential role of D-1 and D-2 receptors. Morelli M; Fenu S; Di Chiara G Neurochem Int; 1992 Mar; 20 Suppl():261S-264S. PubMed ID: 1365438 [TBL] [Abstract][Full Text] [Related]
17. Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats. Gong L; Kostrzewa RM; Brus R; Fuller RW; Perry KW Brain Res Dev Brain Res; 1993 Nov; 76(1):59-65. PubMed ID: 8306431 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. Huang KX; Walters JR J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456 [TBL] [Abstract][Full Text] [Related]
19. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors. Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029 [TBL] [Abstract][Full Text] [Related]
20. Dopamine D1 receptor development depends on endogenous dopamine. Gelbard HA; Teicher MH; Baldessarini RJ; Gallitano A; Marsh ER; Zorc J; Faedda G Brain Res Dev Brain Res; 1990 Oct; 56(1):137-40. PubMed ID: 2149085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]